Spilburg; Curtis A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Spilburg; Curtis A..The latest application filed is for "methods and formulations for converting intravenous and injectable drugs into oral dosage forms".

Company Profile

0.11.11

Spilburg; Curtis A. - Hendersonville NC
SPILBURG; CURTIS A. - Chesterfield MO
Spilburg; Curtis A. - Sunnyvale CA
Spilburg; Curtis A. - St. Louis MO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs Grant 9,107,825 - Spilburg August 18, 2	2015-08-18
Methods And Formulations For Converting Intravenous And Injectable Drugs Into Oral Dosage Forms App 20150031628 - Spilburg; Curtis A.	2015-01-29
Methods And Formulations For Enhancing The Absorption And Decreasing The Absorption Variability Of Orally Administered Drugs, Vitamins And Nutrients App 20150030671 - Spilburg; Curtis A.	2015-01-29
Methods And Formulations For Enhancing The Absorption And Gastro-intestinal Bioavailability Of Hydrophobic Drugs App 20130108689 - Spilburg; Curtis A.	2013-05-02
Methods And Formulations For Enhancing The Absorption And Decreasing The Absorption Variability Of Orally Administered Drugs, Vitamins And Nutrients App 20110111009 - SPILBURG; CURTIS A.	2011-05-12
Methods And Formulations For Converting Intravenous And Injectable Drugs Into Oral Dosage Forms App 20090088393 - SPILBURG; CURTIS A.	2009-04-02
Methods And Formulations For Enhancing The Absorption And Decreasing The Absorption Variability Of Orally Administered Drugs, Vitamins And Nutrients App 20080124387 - SPILBURG; CURTIS A.	2008-05-29
Method and composition for inhibiting cholesterol esterase Grant 7,071,174 - Lange, III , et al. July 4, 2	2006-07-04
Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs App 20060093661 - Spilburg; Curtis A.	2006-05-04
Methods and formulations for enhansing the absorption and gastro-intestinal bioavailability of hydrophobic drugs App 20050244488 - Spilburg, Curtis A.	2005-11-03
Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone App 20050153948 - Spilburg, Curtis A.	2005-07-14
Methods and formulations useful for lowering the cholesterol content of egg yolk App 20040047946 - Spilburg, Curtis A.	2004-03-11
Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs App 20030212046 - Spilburg, Curtis A.	2003-11-13
Method and composition for inhibiting human cholesterol esterase Grant 6,632,801 - Lange, III , et al. October 14, 2	2003-10-14
Mammalian pancreatic cholesterol esterase Grant 5,981,299 - Lance, III , et al. November 9, 1	1999-11-09
Method for recovering purified 100,000 molecular weight fraction of human pancreatic cholesterol esterase using heparin agarose Grant 5,429,937 - Lange, III , et al. July 4, 1	1995-07-04
Mammalian pancreatic cholesterol esterase Grant 5,173,408 - Lange, III , et al. December 22, 1	1992-12-22
Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption Grant 5,063,210 - Lange, III , et al. November 5, 1	1991-11-05
Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase Grant 5,017,565 - Lange, III , et al. May 21, 1	1991-05-21
Collagenase inducing factor Grant 4,752,578 - Moore , et al. June 21, 1	1988-06-21
Method of inhibiting vertebrate collagenase activity using peptide hydroxamic acid derivatives Grant 4,720,486 - Spilburg , et al. January 19, 1	1988-01-19
Peptide hydroxamic acid derivatives Grant 4,687,841 - Spilburg , et al. August 18, 1	1987-08-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.